Sonic Labs approved a governance proposal to launch a Sonic ETF worth $150 million in the US and an entity governing operations in the market.Sonic Labs approved a governance proposal to launch a Sonic ETF worth $150 million in the US and an entity governing operations in the market.

Sonic Labs DAO Approves $150M Sonic ETF Launch to Bridge Crypto with US Capital Market

Blockchain main2

Sonic Labs DAO has authorized a ground-breaking policy proposal to list the S token, the native token of the Sonic blockchain, on the U.S capital markets. Sonic Labs DAO is a community-governed, decentralized, autonomous organization focusing on spearheading the growth of the Sonic blockchain ecosystem. With this calculated move, the DAO is keen on incorporating the cryptocurrency into the traditional investment networks.  

The DAO placed the proposal on voting from 20th August to 31st August, 2025. Following the conclusion of the voting process, the decentralized organization approved the decision, today early morning, to roll out an ETP/ETF that tracks the prices of Sonic cryptocurrency.

Sonic DAO Community Voted To Allow THE Launch of Sonic ETF

According to the data disclosed today by market analyst Satoshi Club, a U.S.-listed ETF/ETP connected to Sonic’s network aims to offer a compliant exposure for traditional investors. BitGo, a digital asset platform offering institutional-focused security and regulated custody solutions, will serve as a custodian for the proposed Sonic’s spot ETF/ETP.

To support the rollout of the ETF/ETP product, Sonic Labs intends to create a U.S.-based subsidiary, dubbed Sonic USA LLC, an entity that will function as a regulatory and operational headquarters for operations in the U.S. The new subsidiary will concentrate on attracting institutional partnerships, adherence to legal compliance, and business growth to build Sonic’s presence in the US market.

The DAO’s proposal also seeks to establish a PIPE (private investment in public equity) product in the US stock exchange, NASDAQ. Sonic Labs plans to leverage the trading of this PIPE offering to attract strategic capital from financial institutions. Together with these three deliberate initiatives, Sonic Labs wants to broaden the accessibility of its native asset to institutional usage and expand its presence in regulated financial markets.  

Sonic Seeking Expand Its Presence in the American Market

Sonic’s move to build its footprint in the US financial markets is part of the crypto project’s effort to support its long-term growth by bolstering adoption, market efficiency, and the legitimacy of its Sonic cryptocurrency. The timing of this proposal happens when Sonic continues to experience surging on-chain activity across its network. The S token witnessed massive growth in July, hitting $4.94 billion in trading volume from $3.1 billion noted in June, which is almost a 60% surge in a single month. Contributing factors for this growth include Sonic’s DeFi surge and rising on-chain activity.

Sonic is currently the 20th largest blockchain by TVL, ahead of Berachain and Cardano, holding $377.11 million in assets locked in DeFi at press time. The ecosystem’s exponential growth in the decentralized finance environment has attracted significant interest from digital asset investors. The rising trading volume, as illustrated above, means Sonic is experiencing stronger customer activity and more robust visibility across the virtual currency market.  

Market Opportunity
Sonic SVM Logo
Sonic SVM Price(SONIC)
$0.07287
$0.07287$0.07287
-1.04%
USD
Sonic SVM (SONIC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23